Royalty Pharma plc
Company Overview
Royalty Pharma plc is a company that buys biopharmaceutical royalties and funds innovation in the life sciences industry. The company's business model involves acquiring royalty interests in marketed and late-stage biopharmaceutical products. They provide capital to research institutions, universities, and biopharmaceutical companies in exchange for royalties on their drug products.
The company generates revenue primarily through royalty payments based on the sales of various biopharmaceutical products for which they own royalty rights. These royalties come from treatments for various conditions including cancer, rare diseases, autoimmune disorders, and other therapeutic areas.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $564.69m | $-103878000.0 | - | $66.51m | 0.00% | 64.02% |
| June 30, 2024 | $537.27m | $316.65m | - | $49.01m | 0.00% | 15.48% |
| March 31, 2024 | $567.98m | $685.98m | - | $44.23m | 0.00% | 6.45% |
Company Impact
Help us evaluate Royalty Pharma plc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.